| Business Type | Exporter, Supplier, Retailer |
| Packaging | Box |
| Color | White |
| Type | Lucielace Elacestrant 345 Mg Tablet |
| Click to view more | |
Product Details
LuciElace 86 mg Tablet contains Elacestrant, a selective estrogen receptor degrader (SERD) indicated for the treatment of estrogen receptor (ER)-positive, HER2-negative advanced or metastatic breast cancer.
\\n
\\n
Uses:
\\n
✔ ER+/HER2- advanced or metastatic breast cancer
\\n
✔ Post-endocrine therapy resistance breast cancer
\\n
\\n
How LuciElace Works:
\\n
Elacestrant is a selective estrogen receptor degrader (SERD) that binds to the estrogen receptor (ER), leading to its degradation and inhibiting ER-driven tumor growth. It is effective even in patients with ESR1 mutations.
\\n
\\n
Dosage & Administration:
\\n
Recommended Dose: 86 mg orally once daily
\\n
\\n
Administration:
\\n
\\n
Take at the same time each day
\\n
\\n
Swallow whole with food; do not crush, chew, or split
\\n
\\n
Continue until disease progression or unacceptable toxicityLuciElace 86 mg Tablet contains Elacestrant, a selective estrogen receptor degrader (SERD) indicated for the treatment of estrogen receptor (ER)-positive, HER2-negative advanced or metastatic breast cancer.
\\n
\\n
Uses:
\\n
✔ ER+/HER2- advanced or metastatic breast cancer
\\n
✔ Post-endocrine therapy resistance breast cancer
\\n
\\n
How LuciElace Works:
\\n
Elacestrant is a selective estrogen receptor degrader (SERD) that binds to the estrogen receptor (ER), leading to its degradation and inhibiting ER-driven tumor growth. It is effective even in patients with ESR1 mutations.
\\n
\\n
Dosage & Administration:
\\n
Recommended Dose: 86 mg orally once daily
\\n
\\n
Administration:
\\n
\\n
Take at the same time each day
\\n
\\n
Swallow whole with food; do not crush, chew, or split
\\n
\\n
Continue until disease progression or unacceptable toxicity
